As of today (2024-04-30), Fulgent Genetics's share price is $20.35.
Fulgent Genetics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.16. Hence, Fulgent Genetics's Price-to-Free-Cash-Flow Ratio for today is 130.45.
The historical rank and industry rank for Fulgent Genetics's Price-to-Free-Cash-Flow or its related term are showing as below:
FLGT'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.89 Med: 36.5 Max: 1518.89
Current: 133.03
During the past 10 years, Fulgent Genetics's highest Price-to-Free-Cash-Flow Ratio was 1518.89. The lowest was 2.89. And the median was 36.50.
FLGT's Price-to-Free-Cash-Flow is ranked worse than 91.01% of 89
companies
in the Medical Diagnostics & Research industry
Industry Median: 26.13
vs FLGT: 133.03
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Fulgent Genetics was -97.80% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -66.80% per year.
During the past 10 years, Fulgent Genetics's highest 3-Year average Free Cash Flow per Share Growth Rate was 215.10% per year. The lowest was -66.80% per year. And the median was 17.30% per year.
Fulgent Genetics Price-to-Free-Cash-Flow Historical Data
The historical data trend for Fulgent Genetics's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fulgent Genetics's Price-to-Free-Cash-Flow
For the Diagnostics & Research subindustry, Fulgent Genetics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fulgent Genetics's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Fulgent Genetics's Price-to-Free-Cash-Flow falls into.
Fulgent Genetics's Share Price of today is $20.35. Fulgent Genetics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Fulgent Genetics Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Fulgent Genetics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Fulgent Genetics (Fulgent Genetics) Business Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FLGT has been successfully added to your 